Petros Pharmaceuticals Stock Quote PTPI - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

0.4651

Bid

0.472

Ask

0.54

Volume

300,040

0.4601 Day's Range 0.50

0.4523 52 Week Range 4.74

Market Cap

1.057M

Previous Close

0.499

Open

0.4779

Last Trade

0.4971

Last Trade Time

Financial Volume

$ 144,456

VWAP

0.481457

Average Volume (3m)

464,768

Shares Outstanding

2,201,069

Dividend Yield

PE Ratio

-0.08

Earnings Per Share (EPS)

-6.28

Revenue

5.82M

Net Profit

-13.81M

Petros Pharmaceuticals Inc is a men's health pharmaceutical company. It focuses on identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including erectile dysfunction, peyronie's disease, hormone health and substance use disorders. The company's ope... Petros Pharmaceuticals Inc is a men's health pharmaceutical company. It focuses on identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including erectile dysfunction, peyronie's disease, hormone health and substance use disorders. The company's operating segment includes Prescription Medications and Medical Devices. It generates maximum revenue from the Prescription Medications segment. The Prescription Medications segment consists primarily of operations related to Stendra, which is sold generally in the United States, and H100 for the treatment of Peyronie's disease. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.petrospharma.com

Headquarters

New York, New York, USA

Founded

1970

Petros Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker PTPI. The last closing price for Petros Pharmaceuticals was $0.50. Over the last year, Petros Pharmaceuticals shares have traded in a share price range of $ 0.4523 to $ 4.74.

Petros Pharmaceuticals currently has 2,201,069 shares outstanding. The market capitalization of Petros Pharmaceuticals is $1.06 million. Petros Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.08.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.1492	-24.2878072603	0.6143	0.65	0.4523	434101	0.49787645	CS
4	-0.1799	-27.8914728682	0.645	0.72	0.4523	230145	0.54749453	CS
12	-0.9349	-66.7785714286	1.4	1.67	0.4523	464768	1.05687519	CS
26	-0.8349	-64.2230769231	1.3	2.27	0.4523	710773	1.2802354	CS
52	-1.9149	-80.4579831933	2.38	4.74	0.4523	463264	1.76393683	CS
156	-29.5349	-98.4496666667	30	52	0.4523	2166800	25.04641748	CS
260	-17.5349	-97.4161111111	18	59.599	0.4523	1873705	25.18712616	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CLEUChina Liberal Education Holdings Ltd	$ 3.1505 (55.97%)	18.32M
HUDAHudson Acquisition I Corporation	$ 16.6999 (52.51%)	636.05k
VEROVenus Concept Inc	$ 0.893101 (52.22%)	69.53M
HRYUHanryu Holdings Inc	$ 0.5047 (40.55%)	2.83M
HUDAUHudson Acquisition I Corporation	$ 15.77 (30.22%)	3.77k
DSYBig Tree Cloud Holdings Limited	1.9091 (-74.67%)	413.98k
BMEABiomea Fusion Inc	$ 4.14 (-63.27%)	11.88M
NBSTWNewbury Street Acquisition Corporation	$ 0.0374 (-32.00%)	174.15k
DHACUDigital Health Acquisition Corporation	$ 15.90 (-30.20%)	2.1k
SCNIScinai Immunotherapeutics Ltd	$ 2.97 (-28.41%)	717.99k
FFIEFaraday Future Intelligent Electric Inc	$ 0.602 (10.66%)	419.77M
PRSTPresto Technologies Inc	$ 0.09 (18.58%)	325.8M
SQQQProShares UltraPro Short QQQ	$ 9.32 (0.32%)	120.35M
CRKNCrown Electrokinetics Corporation	$ 0.0902 (3.20%)	119.61M
GERNGeron Corp	$ 4.60 (18.25%)	98.94M